296 related articles for article (PubMed ID: 28490271)
41. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey.
Yang Q; Liu T; Kuklina EV; Flanders WD; Hong Y; Gillespie C; Chang MH; Gwinn M; Dowling N; Khoury MJ; Hu FB
Arch Intern Med; 2011 Jul; 171(13):1183-91. PubMed ID: 21747015
[TBL] [Abstract][Full Text] [Related]
42. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
Hamer M; Chida Y; Stamatakis E
Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
[TBL] [Abstract][Full Text] [Related]
43. The Effects of Urinary Albumin and Hypertension on All-Cause and Cardiovascular Disease Mortality in Korea.
Seo MH; Lee JY; Ryu S; Won YS; Sung KC
Am J Hypertens; 2017 Aug; 30(8):799-807. PubMed ID: 28472229
[TBL] [Abstract][Full Text] [Related]
44. Cost-effectiveness of risk stratified medication management for reducing premature cardiovascular mortality in Kenya.
Subramanian S; Hilscher R; Gakunga R; Munoz B; Ogola E
PLoS One; 2019; 14(6):e0218256. PubMed ID: 31237910
[TBL] [Abstract][Full Text] [Related]
45. Practical prediction model for the risk of 2-year mortality of individuals in the general population.
Goldfarb-Rumyantzev A; Gautam S; Brown RS
J Investig Med; 2016 Apr; 64(4):848-53. PubMed ID: 26951378
[TBL] [Abstract][Full Text] [Related]
46. Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I).
Alderman MH; Cohen H; Madhavan S
Lancet; 1998 Mar; 351(9105):781-5. PubMed ID: 9519949
[TBL] [Abstract][Full Text] [Related]
47. Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis.
Pearson-Stuttard J; Kypridemos C; Collins B; Mozaffarian D; Huang Y; Bandosz P; Capewell S; Whitsel L; Wilde P; O'Flaherty M; Micha R
PLoS Med; 2018 Apr; 15(4):e1002551. PubMed ID: 29634725
[TBL] [Abstract][Full Text] [Related]
48. The metabolic syndrome and mortality: the Singapore Cardiovascular Cohort Study.
Lee J; Heng D; Ma S; Chew SK; Hughes K; Tai ES
Clin Endocrinol (Oxf); 2008 Aug; 69(2):225-30. PubMed ID: 18208579
[TBL] [Abstract][Full Text] [Related]
49. Dietary intakes of nutrients thought to modify cardiovascular risk from three groups of American Indians: The Strong Heart Dietary Study, Phase II.
Stang J; Zephier EM; Story M; Himes JH; Yeh JL; Welty T; Howard BV
J Am Diet Assoc; 2005 Dec; 105(12):1895-903. PubMed ID: 16321595
[TBL] [Abstract][Full Text] [Related]
50. A comparison of methods for assessing mortality risk.
Levine ME; Crimmins EM
Am J Hum Biol; 2014; 26(6):768-76. PubMed ID: 25088793
[TBL] [Abstract][Full Text] [Related]
51. Assessing the severity of cardiovascular disease in 213 088 patients with coronary heart disease: a retrospective cohort study.
Zghebi SS; Mamas MA; Ashcroft DM; Rutter MK; VanMarwijk H; Salisbury C; Mallen CD; Chew-Graham CA; Qureshi N; Weng SF; Holt T; Buchan I; Peek N; Giles S; Reeves D; Kontopantelis E
Open Heart; 2021 Apr; 8(1):. PubMed ID: 33879507
[TBL] [Abstract][Full Text] [Related]
52. Association of cardiovascular health screening with mortality, clinical outcomes, and health care cost: a nationwide cohort study.
Lee H; Cho J; Shin DW; Lee SP; Hwang SS; Oh J; Yang HK; Hwang SH; Son KY; Chun SH; Cho B; Guallar E
Prev Med; 2015 Jan; 70():19-25. PubMed ID: 25445334
[TBL] [Abstract][Full Text] [Related]
53. A global goodness-of-fit test for receiver operating characteristic curve analysis via the bootstrap method.
Zou KH; Resnic FS; Talos IF; Goldberg-Zimring D; Bhagwat JG; Haker SJ; Kikinis R; Jolesz FA; Ohno-Machado L
J Biomed Inform; 2005 Oct; 38(5):395-403. PubMed ID: 16198998
[TBL] [Abstract][Full Text] [Related]
54. The effects of smoking and physical inactivity on advancing mortality in U.S. adults.
Borrell LN
Ann Epidemiol; 2014 Jun; 24(6):484-7. PubMed ID: 24842763
[TBL] [Abstract][Full Text] [Related]
55. Use of the UKPDS Outcomes Model to predict all-cause mortality in U.S. adults with type 2 diabetes mellitus: comparison of predicted versus observed mortality.
Song M; Alexander CM; Mavros P; Lopez VA; Malik S; Phatak HM; Wong ND
Diabetes Res Clin Pract; 2011 Jan; 91(1):121-6. PubMed ID: 21074286
[TBL] [Abstract][Full Text] [Related]
56. Sodium intake and mortality in the NHANES II follow-up study.
Cohen HW; Hailpern SM; Fang J; Alderman MH
Am J Med; 2006 Mar; 119(3):275.e7-14. PubMed ID: 16490476
[TBL] [Abstract][Full Text] [Related]
57. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
[TBL] [Abstract][Full Text] [Related]
58. Discrimination and calibration of mortality risk prediction models in interventional cardiology.
Matheny ME; Ohno-Machado L; Resnic FS
J Biomed Inform; 2005 Oct; 38(5):367-75. PubMed ID: 16198996
[TBL] [Abstract][Full Text] [Related]
59. Exercise and cardiovascular outcomes by hypertensive status: NHANES I epidemiological follow-up study, 1971-1992.
Fang J; Wylie-Rosett J; Alderman MH
Am J Hypertens; 2005 Jun; 18(6):751-8. PubMed ID: 15925731
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
